Orkla Food Ingredients, through its wholly-owned subsidiary Sonneveld Group, has acquired Dutch company Vamo produkten voor de Bakkerij.
Vamo manufactures specialised concentrates and ingredient mixes to producers of artisan and industrial bakery products.
Established in 1963, Vamo’s headquarters and production facilities are located in Duiven, the Netherlands. Last year, the firm recorded turnover of €12.4 million and EBIT of €1.6 million.
“Vamo is a well-run company with a good customer base and a product portfolio that is a good fit with Sonneveld,” said Peter Verhagen, CEO of Sonneveld.
“The acquisition of Vamo will complement Sonneveld’s position as a supplier of ingredients and accessories to the bakery market.”
The deal sees Orkla continue its spree of acquisitions and follows its purchase last month of a minority stake in Icelandic chocolate company Nói Siríus.
In April, the company’s Orkla Food Ingredients unit secured a deal to buy Zeelandia Sweden, a supplier of margarine, vegetable oils and bakery ingredients.
Norway-headquartered Orkla recently appointed Jaan Ivar Semlitsch as its new CEO, who will take up his position by 1 December at the latest.
Semlitsch is replacing Peter Ruzicka, who stepped down in May following five years in the role.
Source: FoodBev
Schumacher will replace Alan Jope, who announced his decision to retire last September, less than a year after a failed attempt by Unilever to buy GlaxoSmithKline’s consumer healthcare business and just months after activist investor Nelson Peltz joined the company’s board.
Globally, plant-based ice creams have doubled their share of the market over the last five years, according to Tetra Pack. Pea protein and coconut milk are leading the way, but Tetra Pak cites data showing that oat-based ice cream launches have doubled in the previous year.
A myriad of so-called eco-labels are being rolled out across various F&B products, but with no gold standard or strict rules governing precisely what the logos mean and what methodology is behind them, concerns are growing that they will confuse consumers and ultimately be counterproductive.
